Linkedin Live session: A call to action against antimicrobial resistance
EventHumanVeterinaryMedicines
- The original event time is:
- Monday, November 11, 2024 - 11:30 - 12:30 Amsterdam time (CET)
Date
- , -
Location
- European Medicines Agency, Amsterdam, the NetherlandsLive broadcast
Event summary
EMA is organising a Linkedin live discussion with Steffen Thirstrup (PhD, MD), Chief Medical Officer, Anastasia Pickford (PhD, DVM), project manager of EMA's Antimicrobial Sales and Use (ASU) Platform and Alessandro Faia, Press Officer. The main topic of the session is antimicrobial resistance (AMR), a growing silent pandemic that demands immediate and decisive action.
In Europe, at least 35,000 people die from antibiotic-resistant infections every year, with one in five bacterial infections already resistant to antibiotics. Without a strong mobilisation, it is estimated that annual deaths could escalate to 390,000 by 2050.
We urgently need research and development of novel antimicrobials, alternatives to antimicrobials and quick diagnostics to combat antimicrobial resistance. The Linkedin Live session aims to look into the research landscape, the challenges and obstacles that hinder further antimicrobial development, and the available EU regulatory tools to support innovation, research and development by academia and the pharmaceutical industry, big and small.
The Linkedin Live session will also explore the importance of good data to support effective policy-making in the overall fight against AMR. The collection and reporting of data by EU Member States on the sales and use of antimicrobials in animals makes a powerful case for the impact such initiatives can have on public and animal health.
All live viewers are encouraged to participate and ask questions via the comment section. Questions related to the topic can also be sent in advance of the event by email to press@ema.europa.eu and will be answered on 11 November.